glp-1 for diabetes type 2 Receptor Agonist Shortage: Challenges and Solutions in Care GLP-1 drugs are all approved

3 Start losing weight with your customized plan Your medication is shipped discreetly to your door

Anti-inflammatory effects of GLP-1-based therapies beyond glucose control

The Importance of Medical Supervision and Prescribed Dosing Following prescribed dosages is vital for patients using GLP-1 receptor agonists

The SURMOUNT-1 trial tested the ability of tirzepatide to produce weight loss in people with obesity who do not have diabetes

To investigate whether the cutoff of glucose at 3.1 mmol/L impacts the data analysis, we performed a sensitivity analysis using different cut-offs for glucose between 2.7 and 3.4 mmol/L